Search research articles
Contact Us
Filters
Showing results (61-70 of 161) with videos related to
Page
of 17
Sort By:
Vaccine
|
January 5, 2000
Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines
R A Heijtink, P van Bergen, W P Paulij, et al.
Journal of Hepatology
|
November 1, 1990
Phenprocoumon-induced hepatitis mimicking non-A, non-B hepatitis
R A de Man, J H Wilson, S W Schalm, et al.
Scandinavian Journal of Gastroenterology. Supplement
|
February 9, 2005
Doctor-to-patient transmission of hepatitis B virus: the potential of antiviral therapy for prevention
E H C J Buster, A A van der Eijk, R A de Man, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
July 16, 2008
[Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment]
I K Veldhuijzen, M C Mostert, H G M Niesters, et al.
Alimentary Pharmacology & Therapeutics
|
May 7, 1998
Review article: glycyrrhizin as a potential treatment for chronic hepatitis C
T G van Rossum, A G Vulto, R A de Man, et al.
Journal of Hepatology
|
October 6, 1997
Dynamics of hepatitis B virus infection in vivo
S Zeuzem, R A de Man, P Honkoop, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
September 22, 2016
[Diagnostics and treatment of hepatocellular adenomas]
A J Klompenhouwer, R A de Man, M G J Thomeer, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
August 2, 2007
[Diagnosis and treatment of hepatocellular adenoma in the Netherlands: similarities and differences]
D J van der Windt, N F M Kok, R A de Man, et al.
Digestive Diseases and Sciences
|
October 28, 1998
Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy
F ter Borg, S Smorenburg, R A de Man, et al.
Hepatology (Baltimore, Md.)
|
August 1, 2000
A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B
R A de Man, P Marcellin, F Habal, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 161) with videos related to
Sort By:
Page
of 17
Vaccine
|
January 5, 2000
Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines
R A Heijtink, P van Bergen, W P Paulij, et al.
Journal of Hepatology
|
November 1, 1990
Phenprocoumon-induced hepatitis mimicking non-A, non-B hepatitis
R A de Man, J H Wilson, S W Schalm, et al.
Scandinavian Journal of Gastroenterology. Supplement
|
February 9, 2005
Doctor-to-patient transmission of hepatitis B virus: the potential of antiviral therapy for prevention
E H C J Buster, A A van der Eijk, R A de Man, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
July 16, 2008
[Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment]
I K Veldhuijzen, M C Mostert, H G M Niesters, et al.
Alimentary Pharmacology & Therapeutics
|
May 7, 1998
Review article: glycyrrhizin as a potential treatment for chronic hepatitis C
T G van Rossum, A G Vulto, R A de Man, et al.
Journal of Hepatology
|
October 6, 1997
Dynamics of hepatitis B virus infection in vivo
S Zeuzem, R A de Man, P Honkoop, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
September 22, 2016
[Diagnostics and treatment of hepatocellular adenomas]
A J Klompenhouwer, R A de Man, M G J Thomeer, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
August 2, 2007
[Diagnosis and treatment of hepatocellular adenoma in the Netherlands: similarities and differences]
D J van der Windt, N F M Kok, R A de Man, et al.
Digestive Diseases and Sciences
|
October 28, 1998
Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy
F ter Borg, S Smorenburg, R A de Man, et al.
Hepatology (Baltimore, Md.)
|
August 1, 2000
A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B
R A de Man, P Marcellin, F Habal, et al.
Page
of 17